Open Access

Recall for postpartum follow-up of women with gestational diabetes mellitus: Climbing a mountain

  • Hajieh Shahbazian1,
  • Sedigheh Nouhjah1Email author,
  • Shayesteh Jahanfar2 and
  • Morteza Nasiri3
Journal of Diabetes & Metabolic Disorders201615:20

DOI: 10.1186/s40200-016-0245-7

Received: 28 February 2016

Accepted: 29 June 2016

Published: 2 July 2016

Dear editor;

Early postpartum follow-up of women with a history of gestational diabetes mellitus (GDM) provides an opportunity to assess health condition of mothers as well as their offspring health [1]. GDM is considered as the strongest predictor of type 2 diabetes, thus follow-up of women with recent GDM can lead to early diagnosis and management of diabetes and other metabolic disorders outcomes [2].

In developed countries, a low postpartum return rate of women with GDM was reported for assessment of blood glucose [3]. In spite of high prevalence of GDM in Iran [4], evidences about postpartum return rate of women with this disorder and its predicators are not documented adequately.

Given the low postpartum return rate of women with GDM for oral glucose tolerance test and high use of mobile phone in Iran, we compared the effects of two methods of Short Message Service (SMS) text and telephone contact reminders on doing of oral glucose tolerance test (OGTT) for diagnosis of type 2 diabetes among women with GDM to design a novel method for recall of postpartum follow-up. We entered all of women with recent GDM who registered for screening of congenital hypothyroidism of their newborn early days after delivery in two main referral centers of Ahvaz, southwestern of Iran. Totally 476 women with abnormal glucose test in their recent pregnancy were evaluated for eligible criteria during January to March 2015. Among those, 156 women (residents of rural area, no available laboratory records of glucose status during pregnancy, cases of pregestational diabetes, early move out of Ahvaz after parturition, women with literacy problem, no access to mobile phone) were excluded and other 320 women that had inclusion criteria were assigned to receive either 4 SMS texts (n= 160) or 4 telephone contacts (n= 160) with the same dialog during 3–5 days to 6–12 weeks after delivery. SMS texts were sent to women, their husband or both. We asked all women in both groups to return for completion OGTT (a 75-g 2-h oral glucose tolerance test) during 6–12 weeks after delivery. Totally, 90 women (28.12 %) returned and performed OGTT during study period. Among those, 55 women (34.37 %) were in telephone contacts group and 35 women (21.87 %) were in SMS texts group. We concluded that postpartum return rate was higher in women with telephone contacts intervention.

Based on the results of this study, we continued recalling of women in life after gestational diabetes Ahvaz (LAGA) cohort study (IR.AJUMS.REC.1394.252) to compare potential metabolic outcomes in women with GDM (impaired glucose tolerance, diabetes type 2, lipids abnormality and metabolic syndrome) with healthy women. During 6 months recall from March 2015, we registered 1500 pregnant women (after 30 weeks’ gestation) who were referred for prenatal care to Ahvaz public health centers or Ahvaz private clinics to return for postpartum follow-up early after delivery and 2 years afterwards, in baseline visit. We used different methods of communication to recall women to participate. Invitation was sent via social networks (telegram and what’s up), mobile and direct contact via phone for women, their husband or the first relatives who their phone number was available. The baseline visit took place in 25 public and private health centers, and eligible women were invited to refer to cohort study center (Ahvaz Golestan hospital). Until now, data were collected in the first 6–12 weeks after delivery and data collection will continue until March 2017. Data collection tool in this study is a 180-item questionnaire including socio-demographic details, risk factors of gestational diabetes and its potential outcomes, medical and reproductive history, anthropometric measurements, physical activity, dietary intake, and breast feeding. Blood samples were collected in 6–12 weeks postpartum and will repeat annually within the first 2 years after delivery.

After excluded 200 mothers who could not meet study criteria, 1300 eligible women (800 women with GDM and 500 women with normal blood glucose) enrolled. Totally, 230 women (17.69 %) liked to participate in postpartum follow-up. Among those, 180 women (22.5 %) were with GDM and 50 women (10 %) were without GDM. Of women with GDM, 40 cases (5 %) didn’t not return to offered follow-up cohort study center, but reported uptake a test to check their glucose status which ordered by their physician in private clinics. Of those, 32 women (80 %) checked their glycemic status with fasting blood glucose (FBS) and the rest, uptake an OGTT during first weeks after delivery. Overall, return for follow-up and attendance for OGTT was low in early postpartum period in both our studies. It seems that perceived barriers for attendance and checking health status of women with GDM are stronger than the perceived risk of diabetes mellitus and other metabolic outcomes in the future [5].

Based on our experiences, it seems that poor communication between the public and private health sectors, inadequate referral system, lack of a national data registry and integrated health information system in addition to cultural and patient-related barriers are some challenges facing us for follow-up and lead to low rate of follow-up. These problems with controversies in screening, treatment and others concern make this process arduous. So, further research is suggested to explore the influencing factors for postpartum attendance with different methods. Also, it is recommended that with using experiences of other countries in this regard, novel strategies be taken by authorities.

Abbreviations

FBS, Fasting glucose test; GDM, Gestational diabetes mellitus; LAGA, Life after gestational diabetes Ahvaz; OGTT, Oral glucose tolerance test (OGTT); SMS, Short message service

Declarations

Acknowledgements

We appreciate Diabetes Research Center of Ahvaz Jundishapur University of Medical Sciences, Iran, the Research Deputy vice-chancellor for research affairs of the Ahvaz Jundishapur University of Medical Sciences, Iran, for technical support. Also we would like to thank Dr Nahid Shahbazian, Dr Alireza Jahanshahi and Dr Bahman Cheraghian who have supported thoughout the thesis.

Funding

This letter was extracted from ongoing PhD project that is conducted by Sedigheh Nouhjah. This project was approved by Diabetes Research Center of Ahvaz Jundishapur University of Medical Sciences, Iran.

Availability of data and materials

Data will not be shared because the second study is not yet complete and all data is not available totally.

Authors’ contributions

HS participated in acquisition of the data, study concept and design, analysis and interpretation of the data, critical revision of the manuscript for important intellectual content. SN participated in acquisition of the data, study concept and design, analysis and interpretation of the data, drafting of the manuscript and critical revision of the manuscript for important intellectual content. MN participated in analysis and interpretation of the data and drafting of the manuscript. SJ participated in analysis and interpretation of the data and helped to draft the manuscript. NS participated in critical revision of the manuscript for important intellectual content. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent of publication

This article is original and was not published in any other journal. We have declared to give a right to publish in Journal of Diabetes & Metabolic Disorders journal.

Ethics approval and consent to participate

The main project was approved by the Ahvaz Jundishapur University of Medical Sciences University Ethics Committee (IR.AJUMS.REC.1394.252). Informed consent was obtained from all participants women in 2 studies.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences
(2)
School of Population and Public Health, British Columbia University
(3)
Department of Operating Room, Paramedical School, Qom University of Medical Sciences

References

  1. Shih ST, Davis-Lameloise N, Janus ED, Wildey C, Versace VL, Hagger V, et al. Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trial. Trials. 2013;14:339. doi:10.1186/1745-6215-14-339. PMID: 24135085.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Henderson CE, Kavookjian J, Leitstein H, McKoy JM, Murage WJ, Lipman RD. Window of opportunity: Postpartum screening of women with gestational diabetes for early detection of prediabetes and type 2 diabetes. Open Diabetes J. 2012;5(1):25–8. doi:10.2174/1876524601205010025.View ArticleGoogle Scholar
  3. Blatt AJ, Nakamoto JM, Kaufman HW. Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol. 2011;117(1):61–8. doi:10.1097/AOG.0b013e3181fe424b. PMID: 21173645.View ArticlePubMedGoogle Scholar
  4. Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S, Naghavi-Behzad M, Piri R, Pourali-Akbar Y, et al. Prevalence and risk factors of gestational diabetes in Iran: a systematic review and meta-analysis. Iran J Public Health. 2015;44(8):1036–44. PMID: 26587467.PubMedPubMed CentralGoogle Scholar
  5. Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care. 2007;30(9):2281–6. PMID: 17575087.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement